Loránd Kis

Publications
CV
Public outreach and news

Articles

Article: APMIS. 2019;127(8):554-560
PD-L1 expression and deficient mismatch repair in ductal adenocarcinoma of the prostate
Lindh C; Kis L; Delahunt B; Samaratunga H; Yaxley J; Wiklund NP; Clements M; Egevad L
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2019;511(2):260-265
miR-100-5p confers resistance to ALK tyrosine kinase inhibitors Crizotinib and Lorlatinib in EML4-ALK positive NSCLC
Lai Y; Kacal M; Kanony M; Stukan I; Jatta K; Kis L; Norberg E; Vakifahmetoglu-Norberg H; Lewensohn R; Hydbring P; Ekman S
Article: IMMUNOLOGY. 2017;152(4):562-573
Epstein-Barr virus (EBV) provides survival factors to EBV⁺ diffuse large B-cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV⁺DLBCL
Wu L; Ehlin-Henriksson B; Zhou X; Zhu H; Ernberg I; Kis LL; Klein G
Article: NATURE BIOMEDICAL ENGINEERING. 2017;1(10):796-806
Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity
Tanaka N; Kanatani S; Tomer R; Sahlgren C; Kronqvist P; Kaczynska D; Louhivuori L; Kis L; Lindh C; Mitura P; Stepulak A; Corvigno S; Hartman J; Micke P; Mezheyeuski A; Strell C; Carlson JW; Moro CF; Dahlstrand H; Ostman A; Matsumoto K; Wiklund P; Oya M; Miyakawa A; Deisseroth K; Uhlen P
Article: SCIENTIFIC REPORTS. 2016;6:38037
Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.
Rantalainen M; Klevebring D; Lindberg J; Ivansson E; Rosin G; Kis L; Celebioglu F; Fredriksson I; Czene K; Frisell J; Hartman J; Bergh J; Grönberg H
Article: MODERN PATHOLOGY. 2016;29(4):318-329
Digital image analysis outperforms manual biomarker assessment in breast cancer
Stalhammar G; Martinez NF; Lippert M; Tobin NP; Molholm I; Kis L; Rosin G; Rantalainen M; Pedersen L; Bergh J; Grunkin M; Hartman J
Article: CANCER LETTERS. 2015;367(1):76-87
mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells
Karthik G-M; Ma R; Lovrot J; Kis LL; Lindh C; Blomquist L; Fredriksson I; Bergh J; Hartman J
Article: ANTICANCER RESEARCH. 2015;35(2):929-934
β-Catenin Helices in the Cytoplasm of Sessile Serrated Adenoma/Polyps and Conventional Colorectal Adenomas
Rubio CA; Kaufeldt A; Koha R; Ushoida M; Lindahl J; Kis LL
Article: CELL DEATH AND DISEASE. 2014;5(10):e1483
SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth
Ma L; Maruwge W; Strambi A; D'Arcy P; Pellegrini P; Kis L; de Milito A; Lain S; Brodin B
Article: VIRCHOWS ARCHIV. 2013;463(5):637-642
Lymphoid aggregates in Crohn's colitis and mucosal immunity
Rubio CA; Asmundsson J; Silva P; Illies C; Hartman J; Kis L
Article: JOURNAL OF VIROLOGY. 2012;86(8):4701-4707
Latency Type-Dependent Modulation of Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Expression by Type I Interferons in B Cells
Salamon D; Adori M; Ujvari D; Wu L; Kis LL; Madapura HS; Nagy N; Klein G; Klein E
Article: CYTOKINE. 2012;57(3):360-371
Type I interferons directly down-regulate BCL-6 in primary and transformed germinal center B cells: Differential regulation in B cell lines derived from endemic or sporadic Burkitt's lymphoma
Salmon D; Adori M; He M; Bonelt P; Severinson E; Kis LL; Wu L; Ujvari D; Leveau B; Nagy N; Klein G; Klein E
Article: INTERNATIONAL JOURNAL OF CANCER. 2012;130(1):48-58
Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15
Ishii H; Takahara M; Nagato T; Kis LL; Nagy N; Kishibe K; Harabuchi Y; Klein E
Article: BMC CANCER. 2011;11:441
Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines
Otvos R; Skribek H; Kis LL; Gloghini A; Markasz L; Flaberg E; Eksborg S; Konya J; Gergely L; Carbone A; Szekely L
Article: BLOOD. 2011;117(1):165-174
STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma
Kis LL; Gerasimcik N; Salamon D; Persson EK; Nagy N; Klein G; Severinson E; Klein E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2010;107(2):872-877
IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter
Kis LL; Salamon D; Persson EK; Nagy N; Scheeren FA; Spits H; Klein G; Klein E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009;106(29):11966-11971
The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease
Nagy N; Matskova L; Kis LL; Hellman U; Klein G; Klein E
Article: LEUKEMIA AND LYMPHOMA. 2007;48(9):1835-1845
Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel
Markasz L; Kis LL; Stuber G; Flaberg E; Otvos R; Eksborg S; Skribek H; Olah E; Szekely L
Article: INTERNATIONAL JOURNAL OF CANCER. 2006;119(12):2775-2783
Concomitant increase of LMP1 and CD25 (IL-2-receptor α) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3
Takahara M; Kis LL; Nagy N; Liu A; Harabuchi Y; Klein G; Klein E
Article: BLOOD. 2006;107(7):2928-2935
IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma-and NK lymphoma-derived cell lines
Kis LL; Takahara M; Nagy N; Klein G; Klein E
Article: JOURNAL OF PATHOLOGY. 2006;208(3):408-414
Differential expression of oestrogen receptors in human secondary lymphoid tissues
Shim GJ; Gherman D; Kim HJ; Omoto Y; Iwase H; Bouton D; Kis LL; Andersson CT; Warner M; Gustafsson J
Article: VIRUS GENES. 2005;30(3):323-330
EBV infection induces expression of the transcription factors ATF-2/c-Jun in B lymphocytes but not in B-CLL cells
Bandobashi K; Liu AQ; Nagy N; Kis LL; Nishikawa J; Björkholm M; Klein G; Klein E
Article: INTERNATIONAL JOURNAL OF CANCER. 2005;113(6):937-945
In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2
Kis LL; Nishikawa J; Takahara M; Nagy N; Matskova L; Takada K; Elmberger PG; Ohlsson A; Klein G; Klein E
Article: ONCOGENE. 2004;23(53):8563-8570
Wild-type p53 activates SAP expression in lymphoid cells
Nagy N; Takahara M; Nishikawa J; Bourdon JC; Kis LL; Klein G; Klein E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2004;101(6):1720-1724
Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene.
Shim G-J; Kis LL; Warner M; Gustafsson J-A
Article: VIRUS GENES. 2004;28(1):121-128
Upregulation of LMP1 expression by histone deacetylase inhibitors in an EBV carrying NPC cell line
Nishikawa J; Kis LL; Liu AQ; Zhang XN; Takahara M; Bandobashi K; Kiss C; Nagy N; Okita K; Klein G; Klein E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2003;100(11):6694-6699
Disruption of the estrogen receptor β gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis
Shim GJ; Wang L; Andersson S; Nagy N; Kis LL; Zhang QH; Mäkelä S; Warner M; Gustafsson J
Article: INTERNATIONAL JOURNAL OF CANCER. 2003;104(5):658-661
Expression of SH2D1A in five classical Hodgkin's disease-derived cell lines
Kis LL; Nagy N; Klein G; Klein E
Article: INTERNATIONAL JOURNAL OF CANCER. 2002;100(4):433-440
SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation
Nagy N; Maeda A; Bandobashi K; Kis LL; Nishikawa J; Trivedi P; Faggioni A; Klein G; Klein E
Show more

All other publications

Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2018;180(5):744-748
CD274 (PD-L1)/PDCD1 (PD-1) expression in de novo and transformed diffuse large B-cell lymphoma
Kwiecinska A; Tsesmetzis N; Ghaderi M; Kis L; Saft L; Rassidakis GZ
Review: JOURNAL OF CLINICAL PATHOLOGY. 2018;71(1):7-11
The third pathway of colorectal carcinogenesis
Rubio CA; Puppa G; de Petris G; Kis L; Schmidt PT
Corrigendum: NATURE BIOMEDICAL ENGINEERING. 2018;2(1):48
Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity (vol 1, pg 796, 2017)
Tanaka N; Kanatani S; Tomer R; Sahlgren C; Kronqvist P; Kaczynska D; Louhivuori L; Kis L; Lindh C; Mitura P; Stepulak A; Corvigno S; Hartman J; Micke P; Mezheyeuski A; Strell C; Carlson JW; Moro CF; Dahlstrand H; Ostman A; Matsumoto K; Wiklund P; Oya M; Miyakawa A; Deisseroth K; Uhlen P
Letter: ANNALS OF ONCOLOGY. 2017;28(7):1672-1673
Lethal aplastic anemia caused by dual immune checkpoint blockade in metastatic melanoma
Helgadottir H; Kis L; Ljungman P; Larkin J; Kefford R; Ascierto PA; Hansson J; Masucci G
Letter: LEUKEMIA. 2017;31(7):1633-1637
PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma
Atsaves V; Tsesmetzis N; Chioureas D; Kis L; Leventaki V; Drakos E; Panaretakis T; Grander D; Medeiros LJ; Young KH; Rassidakis GZ
Thesis / dissertation: 2009
The role of the microenvironment on the regulation of Epstein-Barr virus latent gene expression
Kis, Loránd Levente
Review: ONCOGENE. 2007;26(9):1297-1305
Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions
Klein E; Kis LL; Klein G
Review: ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA. 2006;53(4):441-457
Pathogenesis of Epstein-Barr virus (EBV)-carrying lymphomas.
Klein E; Kis LL; Takahara M
Published conference paper: IMMUNOLOGY LETTERS. 2006;104(1-2):83-88
Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1
Kis LL; Takahara M; Nagy N; Klein G; Klein E
Letter: LEUKEMIA. 2005;19(10):1854-1856
Epigenetic mechanisms do not control viral latency III in primary effusion lymphoma cells infected with a recombinant Epstein-Barr virus
Anastasiadou E; Boccellato F; Cirone M; Kis LL; Klein E; Frati L; Faggioni A; Trivedi P

Employments

Affiliated to Research, Department of Oncology-Pathology, Karolinska Institutet, 2023-2026

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 2009

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI